Avenacy Enters New Asset-Based Lending Agreement with Texas Capital Bank
Avenacy, a specialty pharmaceutical company committed to supplying critical injectable medications to the U.S. market, entered into an asset-based lending (ABL) agreement with Texas Capital Bank. The agreement provides Avenacy with the financial flexibility to accelerate its growth and support...
Read moreDetails








